CLT-010-71S

N/A

Report date: 2024/01/25 09:18:07

Base Information

Drug NameCLT-010-71S
Drug Alias NameCLT-010-71S
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWnt signalling pathway inhibitorsCatenin beta 1 inhibitors
TargetsCatenin beta 1
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCharlesson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharlesson
Active IndicationsN/A
Inactive IndicationsDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A